Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aderbasib + Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00864175Phase 2Terminated
- Sponsor
- Incyte
- Start
- Jul 2007
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aderbasib in HER2-positive metastatic breast cancer, sponsored by Incyte. Started Jul 2007; status: terminated.
02
Drugs
aderbasib
03
Conditions
HER2-positive metastatic breast cancer
Beyond the preview
Go deeper on NCT00864175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00864175.